Penaeus monodon tropomyosin induces CD4 T-cell proliferation in shrimp-allergic patients

Human Immunology

Volumn 73, Issue 4, 2012, Pages 426-431

  Wang, Shuping ^a   Delgado, Julio C ^b   Ravkov, Eugene ^b   Eckels, David D ^a   Georgelas, Ann ^c   Pavlov, Igor Y ^b   Cusick, Matthew ^a   Sebastian, Kate ^a   Gleich, Gerald J ^a   Wagner, Lori A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Allergy; Epitopes; Shrimp; T cells

Indexed keywords

EPITOPE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; TROPOMYOSIN;

ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FOOD ALLERGY; HISTORY; HUMAN; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; PENAEUS MONODON; PERIPHERAL BLOOD MONONUCLEAR CELL; PRICK TEST; PRIORITY JOURNAL; SHRIMP;

ALLERGENS; AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PENAEIDAE; PEPTIDES; SKIN TESTS; TROPOMYOSIN;

EID: 84862822781     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.12.019     Document Type: Article

References (32)

1. Sicherer S.H., Munoz-Furlong A., Sampson H.A. Prevalence of seafood allergy in the United States determined by a random telephone survey. J Allergy Clin Immunol 2004, 114:159-165.
2. Shanti K.N., Martin B.M., Nagpal S., Metcalfe D.D., Rao P.V. Identification of tropomyosin as the major shrimp allergen and characterization of its IgE-binding epitopes. J Immunol 1993, 151:5354-5363.
3. Nagpal S., Metcalfe D.D., Rao P.V. Identification of a shrimp-derived allergen as tRNA. J Immunol 1987, 138:4169-4174.
4. Yu C.J., Lin Y.F., Chiang B.L., Chow L.P. Proteomics and immunologic analysis of a novel shrimp allergen, Pen m 2. J Immunol 2003, 170:445-453.
5. Ayuso R., Grishina G., Ibanez M.D., Blanco C., Carrillo T., Bencharitiwong R., Sanchez S., Nowak-Wegrzyn A., Sampson H.A. Sarcoplasmic calcium-binding protein is an EF-hand-type protein identified as a new shrimp allergen. J Allergy Clin Immunol 2009, 124:114-120.
6. Leung P.S., Chow W.K., Duffey S., Kwan H.S., Gershwin M.E., Chu K.H. IgE reactivity against a cross-reactive allergen in crustacea and mollusca: Evidence for tropomyosin as the common allergen. J Allergy Clin Immunol 1996, 98:954-961.
7. Leung P.S., Chen Y.C., Gershwin M.E., Wong S.H., Kwan H.S., Chu K.H. Identification and molecular characterization of Charybdis feriatus tropomyosin, the major crab allergen. J Allergy Clin Immunol 1998, 102:847-852.
8. Santos A.B., Chapman M.D., Aalberse R.C., Vailes L.D., Ferriani V.P., Oliver C., Rizzo M.C., Naspitz C.K., Arruda L.K. Cockroach allergens and asthma in Brazil: Identification of tropomyosin as a major allergen with potential cross-reactivity with mite and shrimp allergens. J Allergy Clin Immunol 1999, 104:329-337.
9. Fernandes J., Reshef A., Patton L., Ayuso R., Reese G., Lehrer S.B. Immunoglobulin E antibody reactivity to the major shrimp allergen, tropomyosin, in unexposed Orthodox Jews. Clin Exp Allergy 2003, 33:956-961.
10. Ayuso R., Lehrer S.B., Reese G. Identification of continuous, allergenic regions of the major shrimp allergen Pen a 1 (tropomyosin). Int. Arch Allergy Immunol 2002, 127(1):27-37.
11. Rolland J.M., Gardner L.M., O'Hehir R.E. Allergen-related approaches to immunotherapy. Pharmacol Ther 2009, 121:273-284.
12. Broide D.H. Immunomodulation of allergic disease. Annu Rev Med 2009, 60:279-291.
13. Gleich G.J., Zimmermann E.M., Henderson L.L., Yunginger J.W. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: A six-year prospective study. J Allergy Clin Immunol 1982, 70:261-271.
14. Khinchi M.S., Poulsen L.K., Carat F., Andre C., Hansen A.B., Malling H.J. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: A randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004, 59:45-53.
15. Smith H., White P., Annila I., Poole J., Andre C., Frew A. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 2004, 114:831-837.
16. Bilo M.B., Severino M., Cilia M., Pio A., Casino G., Ferrarini E., Campodonico P., Milani M. The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified versus nonpurified extracts. Ann Allergy Asthma Immunol 2009, 103:57-61.
17. Nieminen K., Valovirta E., SavolainenJ Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapy. Pediatric Allergy and Immunology 2009.
18. Gadermaier E., Flicker S., Aberer W., Egger C., Reider N., Focke M., Vrtala S., Kundi M., Valenta R. Analysis of the Antibody Responses Induced by Subcutaneous Injection Immunotherapy with Birch and Fagales Pollen Extracts Adsorbed onto Aluminum Hydroxide. Int. Arch Allergy Immunol 2009, 151(1):17-27.
19. Dal R., Kapp A., Colombo G., de Monchy J.G., Rak S., Emminger W., Rivas M.F., Ribel M., Durham S.R. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006, 118:434-440.
20. Muller U., Akdis C.A., Fricker M., Akdis M., Blesken T., Bettens F., Blaser K. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998, 101:747-754.
21. Bateman E.A., Ardern-Jones M.R., Ogg G.S. Identification of an immunodominant region of Fel d 1 and characterization of constituent epitopes. Clin Exp Allergy 2008, 38:1760-1768.
22. Masuyama K., Chikamatsu K., Ikagawa S., Matsuoka T., Takahashi G., Yamamoto T., et al. Analysis of helper T cell responses to Cry j 1-derived peptides in patients with nasal allergy: Candidate for peptide-based immunotherapy of Japanese cedar pollinosis. Allergol Int 2009, 58:63-70.
23. Old field W.L., Larche M., Kay A.B. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: A randomized controlled trial. Lancet 2002, 360:47-53.
24. Campbell J.D., Buckland K.F., McMillan S.J., Kearley J., Old field W.L., Stern L.J., Gronlund H., van Hage M., Reynolds C.J., Boyton R.J., Cobbold S.P., Kay A.B., Altmann D.M., Lloyd C.M., Larche M. Peptide immunotherapy in allergic asthma generates IL-10-dependent immunologic tolerance associated with linked epitope suppression. J Exp Med 2009, 206:1535-1547.
25. Moingeon P., Batard T., Fadel R., Frati F., Sieber J., Van Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006, 61:151-165.
26. + T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003, 111:1255-1261.
27. Bohle B., Kinaciyan T., Gerstmayr M., Radakovics A., Jahn-Schmid B., Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007, 120:707-713.
28. Bellinghausen I., Metz G., Enk A.H., Christmann S., Knop J., Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997, 27:1131-1139.
29. Akdis C.A., Blesken T., Akdis M., Wuthrich B., Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998, 102:98-106.
30. Quah B.J., Warren H.S., Parish C.R. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2007, 2:2049-2056.
31. Greaser M.L., Gergely J. Reconstitution of troponin activity from 3 protein components. J Biol Chem 1971, 246:4226-4233.
32. Tarzi M., Klunker S., Texier C., Verhoef A., Stapel S.O., Akdis C.A., Maillere B., Kay A.B., Larche M. Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy 2006, 36:465-474.